Portal-Nuñez S - Search Results

1

The combined therapy with chondroitin sulfate plus glucosamine sulfate or chondroitin sulfate plus glucosamine hydrochloride does not improve joint damage in an experimental model of knee osteoarthritis in rabbits.

Roman-Blas JA, Mediero A, Tardío L, Portal-Nuñez S, Gratal P, Herrero-Beaumont G, Largo R. Roman-Blas JA, et al. Eur J Pharmacol. 2017 Jan 5;794:8-14. doi: 10.1016/j.ejphar.2016.11.015. Epub 2016 Nov 12. Eur J Pharmacol. 2017. PMID: 27845067

2

Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritis.

Portal-Núñez S, Esbrit P, Alcaraz MJ, Largo R. Portal-Núñez S, et al. Biochem Pharmacol. 2016 May 15;108:1-10. doi: 10.1016/j.bcp.2015.12.012. Epub 2015 Dec 19. Biochem Pharmacol. 2016. PMID: 26711691 Review.

3

Unexpected Bone Formation Produced by RANKL Blockade.

Portal-Núñez S, Mediero A, Esbrit P, Sánchez-Pernaute O, Largo R, Herrero-Beaumont G. Portal-Núñez S, et al. Trends Endocrinol Metab. 2017 Oct;28(10):695-704. doi: 10.1016/j.tem.2017.06.003. Epub 2017 Jul 19. Trends Endocrinol Metab. 2017. PMID: 28733136 Review.

4

Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains.

Portal-Núñez S, Ardura JA, Lozano D, Martínez de Toda I, De la Fuente M, Herrero-Beaumont G, Largo R, Esbrit P. Portal-Núñez S, et al. Bone Joint Res. 2018 Jan;7(1):58-68. doi: 10.1302/2046-3758.71.BJR-2016-0242.R2. Bone Joint Res. 2018. PMID: 29330344 Free PMC article.

5

Blocking chondrocyte hypertrophy in conditional Evc knockout mice does not modify cartilage damage in osteoarthritis.

Lamuedra A, Gratal P, Calatrava L, Ruiz-Perez VL, Palencia-Campos A, Portal-Núñez S, Mediero A, Herrero-Beaumont G, Largo R. Lamuedra A, et al. Among authors: portal nunez s. FASEB J. 2022 Apr;36(4):e22258. doi: 10.1096/fj.202101791RR. FASEB J. 2022. PMID: 35334131

6

The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia.

Lozano D, Fernández-de-Castro L, Portal-Núñez S, López-Herradón A, Dapía S, Gómez-Barrena E, Esbrit P. Lozano D, et al. Br J Pharmacol. 2011 Mar;162(6):1424-38. doi: 10.1111/j.1476-5381.2010.01155.x. Br J Pharmacol. 2011. PMID: 21175568 Free PMC article.

7

[Pathophysiology of aging bone].

Portal-Núñez S, Lozano D, de la Fuente M, Esbrit P. Portal-Núñez S, et al. Rev Esp Geriatr Gerontol. 2012 May-Jun;47(3):125-31. doi: 10.1016/j.regg.2011.09.003. Epub 2011 Dec 14. Rev Esp Geriatr Gerontol. 2012. PMID: 22172573 Review. Spanish.

8

Role of the N- and C-terminal fragments of parathyroid-hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment.

de Castro LF, Lozano D, Dapía S, Portal-Núñez S, Caeiro JR, Gómez-Barrena E, Esbrit P. de Castro LF, et al. Tissue Eng Part A. 2010 Apr;16(4):1157-68. doi: 10.1089/ten.TEA.2009.0355. Tissue Eng Part A. 2010. PMID: 19860552

9

Characterization of skeletal alterations in a model of prematurely aging mice.

Portal-Núñez S, Manassra R, Lozano D, Acitores A, Mulero F, Villanueva-Peñacarrillo ML, De la Fuente M, Esbrit P. Portal-Núñez S, et al. Age (Dordr). 2013 Apr;35(2):383-93. doi: 10.1007/s11357-011-9372-8. Epub 2012 Jan 11. Age (Dordr). 2013. PMID: 22234865 Free PMC article.

10

Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies.

Esbrit P, Herrera S, Portal-Núñez S, Nogués X, Díez-Pérez A. Esbrit P, et al. Calcif Tissue Int. 2016 Apr;98(4):359-69. doi: 10.1007/s00223-015-0050-1. Epub 2015 Aug 11. Calcif Tissue Int. 2016. PMID: 26259869 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters